0 results available. Select is focused ,type to refine list, press Down to open the menu,
Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...
The following section summarizes insights on Novartis AG's 1 Week Price Total Return:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to 1 Week Price Total Return in the valuation category include:
The total change in price (adjusted of dividends and splits when applicable) over the last 1 week.
The 1 week price total return measures the total change in price (adjusted of dividends and splits when applicable) over the last 1 week. If the company pays dividends, the starting stock price is adjusted down to include the return in the form of dividends.
Last Close Price / Adj Prior Close Price
(-) 1
(=) Total Return
One Week Stock Price Total Return for Novartis is calculated as follows:
Last Close Price [ 96.11 ] / Adj Prior Close Price [ 99.78 ]
(-) 1
(=) Total Return [ −3.7% ]
Prior price dividend adjustment factor is 1.00.
Read more about price close (split adjusted) and dividend adjustment factor
The chart above depicts the distribution of 1 week price total return for companies operating in the Healthcare sector in the Developed economic region. Over 3,140 companies were considered in this analysis, and 3,022 had meaningful values. The average 1 week price total return of companies in the sector is -0.7% with a standard deviation of 7.3%.
Novartis AG's 1 Week Price Total Return of -3.7% ranks in the 23.8% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 3,147 |
| Included Constituents | 3,022 |
| Min | -28.6% |
| Max | 32.7% |
| Median | 0.0% |
| Mean | -0.7% |
| Standard Deviation | 7.3% |
You can find companies with similar 1 week price total return using this stock screener.